ClinicalTrials.gg
RecruitingNCT07009028Updated Jun 6, 2025

The Effect of Storigami Method on Pain, Fear and Anxiety Levels Associated With Peripheral Intravenous Catheterisation in Children

An interventional study of Storigami figure in Pain, sponsored by Ege University. Recruiting at 2 sites in Turkey. Open to participants aged 6 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-06.

Sponsored by Ege University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
6 Years to 9 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Pain by Ege University — 6 open to participants now, 7 under way, none of them phase 3. Pain · Ege University.

Planned enrollment
9th of 30
120 · median 100
Started
2025
the only one that year
No phase
29 of 31
6 open now
Registered
23rd of 31
by date

Among the 31 studies in Pain by Ege University, this one is the 9th largest by planned enrollment of the 30 interventional ones that give a count, is the only one that started in 2025, is one of 29 with no phase, and was the 23rd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

6 of the 31 studies in Pain by Ege University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 6 Years to 9 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Pain by Ege University, or all of them as a file.
02

Study summary

The aim of this study was to determine the effect of storigami method on reducing pain, fear and anxiety of children in peripheral intravenous catheter applications in children aged 6-9 years who were hospitalized in the pediatric health and diseases clinic.

Read the detailed description

He stated that children and their families who frequently visit hospitals for follow-up, treatment or various anomalies have negative hospital experiences due to fear, anxiety and painful procedures, and that these negative experiences may cause phobias and avoidance of medical procedures in children in the future. Therefore, this study was planned to determine the effect of storigami method on reducing pain, fear and anxiety of children in peripheral intravenous catheter applications in children aged 6-9 years who were hospitalized in the pediatric health and diseases clinic. Storigami is a method that involves the use of origami and stories at the same time and can be used to reduce pain in hospitals. The method, which is planned to be used to minimize negative hospital experiences, is thought to be a promising, cost-effective and safe non-pharmacological technique that can be used safely to reduce fear, anxiety and pain of hospitalized patients.

03

Conditions studied

  • Pain

Browse trials for

Keywords

  • nurse
  • child
  • distraction methods
04

Who can participate

Ages eligible
6 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteering to participate in the study
  • The child is between 6-9 years old
  • First time peripheral intravenous catheter insertion since admission to the clinic
  • The child has no vision, hearing and speech problems
  • The child has no mental retardation
  • Know/speak Turkish
  • No complaints such as pain, nausea and vomiting that may affect fear and anxiety
  • No sedative or analgesic was given to the child immediately before the peripheral intravenous catheterization procedure

Exclusion criteria

Exclusion Criteria:

  • The child has a chronic, congenital, metabolic or neurodegenerative disease
  • Failed attempt at peripheral intravenous catheterization,
  • Failure to complete or incomplete completion of questionnaires,
  • A different invasive intervention was performed immediately before PIC application,
  • The child does not comply during the procedure,
  • The child wants to leave the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • No intervention
    Arms

    No Intervention: children will receive standard care during peripheral intravenous catheterization.

  • Experimental
    Arm

    Experimental:storigami method will be applied during peripheral intravenous catheterization of children

    Combination Product: Storigami figure

Interventions

  • Combination productStorigami figure

    Combination Produc: The origami figure that will be formed as a result of the process will be used as a distraction method

06

What researchers measure

Primary outcomes

  1. Reducing the child's fear

    The Children's Fear Scale (CFS) was graded on a scale of 0-4 and included five display images with facial expressions ranging from neutral (0 = no anxiety) to fearful (4 = severe anxiety). Children between the ages of 5 and 10 can use it before and after treatments. For child and proxy reports, it contain different instructions to reduce the child's fear during the peripheral intravenous catheterization procedure.

    Time frame: during peripheral intravenous procedure

  2. Reducing the child's anxiety

    Child Anxiety Scale-State (CASsingle bondS). Its bottom resembles a lightbulb, and its horizontal lines with upward ranges like those of a thermometer. To measure state anxiety, the child is asked to say that he feels "now" It applied to kids ages 4 to 12 and had a range of 0 to 10. There is a direction in the scale "NOW color where you FEEL on the thermometer, too much tension or anxious, calm: not tension or anxious? Children were asked to "Pretend that all your worried or nervous feelings are in the very bottom down here (point to scale). If you are a little bit worried or nervous, the feelings might come up just a little bit (move your finger up). If you are very, very worried or nervous, the feelings might go all the way to the top (move your finger up to the top). Put a line showing how much worry or nervousness you feel." It ranges from 0 to 10 and can be applied to children aged 4-12. Reduce the child's anxiety during the peripheral intravenous catheterization procedure

    Time frame: during peripheral intravenous procedure

  3. Reducing the child's pain

    This scale, which has six faceted expressions and assigns a pain score based on the numerical values of the faces, is used to diagnose pain in children. It is used to assess the pain in children three years and older. Faces can display a range of emotions, from crying (10 = most painful) to smiling (0 = no pain) reduce the child's pain during the peripheral intravenous catheterization procedure

    Time frame: during peripheral intravenous procedure

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Aug 2025, 3 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
May 20, 2025
First posted
Jun 6, 2025
StartActual
May 20, 2025
Primary completionEst.
Aug 20, 2025
CompletionEst.
Aug 30, 2025
Last update
Jun 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07009028
Lead sponsor
Ege University
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Ayşe Kahraman (Assoc. Prof. Dr., Ege University) — Principal investigator
First posted
Jun 6, 2025
Start date
May 20, 2025
Primary completion
Aug 20, 2025 (estimated)
Completion
Aug 30, 2025 (estimated)
Last update
Jun 6, 2025

Study contacts

Emine ÇUBUKCU, MSc
Contact
eminacubukcu@gmail.com
+905358700970
Ayşe Kahraman, Assoc Prof
Contact
ayse.ersun@gmail.com
+905543486221
Ayşe Kahraman, Assoc Prof
principal investigator · Ege Universty

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion